共 17 条
[2]
Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224
[4]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
[J].
JOURNAL OF CHRONIC DISEASES,
1987, 40 (05)
:373-383
[7]
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment: (the GFPC 0505 study)
[J].
LUNG CANCER,
2012, 77 (01)
:97-103
[8]
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)
[J].
BRITISH JOURNAL OF CANCER,
2011, 105 (08)
:1123-1130